Trypa-NO! contributes to the elimination of gambiense human African trypanosomiasis by combining tsetse control with "screen, diagnose and treat" using innovative tools and strategies.

Contributes to the elimination of gambiense human African trypanosomiasis by combining tsetse control with "screen, diagnose and treat" using innovative tools and strategies Partnership strategy integrates tsetse control with screening, diagnosis, and treatment of g-HAT cases and a system of collection and transfer of data into a Central Information Repository (CIR). Initial trials in Uganda [[21]], Guinea [[5]], and Chad [[6]] showed that Tiny Targets rapidly reduced tsetse densities by 60% to 80% and the incidence of g-HAT, with at least 70% of the reduction in g-HAT incidence attributed to their use [[5]]. Following the trials, tsetse control has been implemented at scale in the active g-HAT foci of Guinea from 2012, Chad from 2013, Uganda from 2014, and Côte d'Ivoire from 2017. [Extracted from the article]